UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000020370
Receipt No. R000023525
Scientific Title Phase 2 trial of the efficacy and safety of Afatinib for EGFR-TKI untreated EGFR gene mutation-Positive Elderly advanced or recurrent non-small cell lung Cancer. (APEC)
Date of disclosure of the study information 2015/12/27
Last modified on 2018/12/30 11:22:41

No. Disposal Last modified on Item of update
1 Insert 2015/12/27 21:45:32
2 Update 2016/12/26 18:10:04 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Division name
Email
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Name of primary sponsor
Organization
Email1
Institutions
3 Update 2017/06/28 10:31:58 Organization
Organization
Division name
Division name
Address
Address
TEL
Email
Organization1
Address1
Tel1
Email1
Institutions
4 Update 2017/06/28 10:36:18 Last follow-up date
5 Update 2018/12/30 11:22:41 Recruitment status
Last follow-up date


Contact us.